INS and diabetes mellitus: According to Diabetes Canada—Clinical Practice Guidelines Expert Committee for the in-hospital management of diabetes, scheduled subcutaneous insulin administration that consists of basal, bolus (prandial) and correction (supplemental) insulin components is the preferred method for achieving and maintaining glucose control in non-critically ill hospitalized patients, including surgery patients with diabetes who are eating [26].